Biggest News Aggregation in the World
📰 Car Therapy Development News

Car Therapy Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Car Therapy Development. Real-time updates on events, politics, business and more.

Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2021: Analysis of Yescarta, Tecartus, Kymriah, Breyanzi, & Abecma

/PRNewswire/ -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.coms...
United States Laura Wood Barriers To Research Company Specific Intellectual Property Formula Pharmaceuticals Inc Gilead Sciences Inc

Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2021: Analysis of Yescarta, Tecartus, Kymriah, Breyanzi, & Abecma

/PRNewswire/ -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.coms...
United States Laura Wood Barriers To Research Company Specific Intellectual Property Formula Pharmaceuticals Inc Gilead Sciences Inc

Worldwide CAR T-Cell Therapy Industry to 2030 - Players Include Legend Biotech, Novartis & Pfizer Among Others

Share this article Share this article ResearchAndMarkets.coms offering. The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patients immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include incre...
United States South Korea Brexucabtagene Autoleucel Tecartus Axicabtagene Ciloleucel Tisagenlecleucel Kymriah Idecaptagene Cicleucel

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science